SXTP
60 Degrees Pharmaceuticals, Inc.
$1.55
-0.07 (-4.32%)
At close · Jul 8
Market Cap
$4.12M
Shares
2,659,288
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.55
Open$1.52
Day$1.46–1.58
52W$1.22–10.77
Avg vol 30d131K
Short int151K · 5.7% float · 1.0d
Short vol29%
DataJul 2023–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−50%
below
Price vs 50-day avg
+0%
above
RSI (14)
46
neutral
MACD trend
Negative
52-week position
3%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+8%
trailing
6-month return
−27%
trailing
YTD return
−24%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+8 funds added
Insider flow
Accumulating
Net +$10.1K over 90 days · 0% sells
Short interest
Rising
5.67% of float · ▲ +15.5% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
8 holders — 13F breadth
Squeeze score
34
low risk · 0–100
Fundamentals
Revenue growth
+65%
Y/Y
Gross margin
22%
contracting
EPS growth
+84%
Y/Y
Free cash flow
$-7.0M
Balance sheet
$1.6M
net debt
Quant / Vol
risk profile
Volatility
197%
annualized · 1-yr
Max drawdown
−87%
past year
ATR
9.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−50%
Bearish
Price vs 50-day avg
+0%
Bullish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+8 funds added
Insider flow
Accumulating
Net +$10.1K over 90 days · 0% sells
Short interest
Rising
5.67% of float · ▲ +15.5% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
8 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $1
Now $2 · 3%
52-wk high $11
vs 200-day avg -50%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SXTP
this stock
60 Degrees Pharmaceuticals, Inc.
|
$4.12M | -23.7% | +65.5% | — | 5.7% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SXTP | -11.9% | +8.4% | -26.6% | -11.9% | -23.7% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -11.8% | +7.6% | -34.1% | -11.8% | -33.0% |